Dipharma

Dipharma is a global Contract Development and Manufacturing Organization (CDMO) and Active Pharmaceutical Ingredients (API) manufacturer, established in 1949. Employing over 500 staff, the company operates four cGMP plants and commercial offices across Italy, the USA, and China. Dipharma specializes in exclusive synthesis services and offers a comprehensive catalogue of APIs for the generic market. It positions itself as a trusted partner, focused on minimizing development and manufacturing burdens for clients while ensuring high-quality standards and innovative solutions. Their commitment to sustainability and global presence enables effective support for pharmaceutical industry clients.

The company's operational scale and dedicated workforce are central to its success. Meet Dipharma's team to understand the expertise driving their operations. Dipharma's business model emphasizes streamlining client processes through efficient, high-quality production. Their strategic global presence, coupled with a deep understanding of pharmaceutical manufacturing, allows them to effectively support clients navigating the complexities of the healthcare and pharmaceutical sectors. The company's dedication extends to sustainable practices, ensuring responsible manufacturing alongside its core business objectives.

Dipharma's product portfolio includes a wide range of pharmaceutical ingredients, serving as a critical supplier for various therapeutic areas. Their expertise in chemical synthesis and API development positions them as a key player in the pharmaceutical supply chain. By focusing on both custom synthesis and a broad API offering, Dipharma caters to diverse client needs, from early-stage development to commercial-scale production. This dual approach, combined with a legacy of nearly 75 years, underscores their enduring commitment to advancing pharmaceutical manufacturing and contributing to global healthView more...